Evidence map›Paper›PMID 24888709›Full record

ReviewReviews in medical virology2014

Human cytomegalovirus tropism for mucosal myeloid dendritic cells.

Laura Hertel

Abstract readReview
In one paragraph

Review in Reviews in medical virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Cytomegalovirus infection during pregnancy.Obstetrics & gynecology science · 2023
    Article
  2. Article
  3. Review
  4. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  5. Single-Cell Transcriptome Analysis of CD34Frontiers in microbiology · 2019
    Article
  6. Article
  7. The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Laura HertelCenter for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, CA, 94609, USA.

Funding

Mechanisms mediating HCMV genome maintenance during latencyR01AI099372 · NIAID · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI HERTEL, LAURA · 2013 to 2017
$1.8M
Mechanisms mediating HCMV genome maintenance during latencyR56AI099372 · NIAID · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI HERTEL, LAURA · 2012 to 2012
$236k
CIHRNIAID NIH HHS AI099372NIAID NIH HHS R01 AI099372NIAID NIH HHS R56 AI099372
6 · The paper itself

Abstract

Human CMV infections are a serious source of morbidity and mortality for immunocompromised patients and for the developing fetus. Because of this, the development of new strategies to prevent CMV acquisition and transmission is a top priority. Myeloid dendritic cells (DC) residing in the oral and nasal mucosae are among the first immune cells to encounter CMV during entry and greatly contribute to virus dissemination, reactivation from latency, and horizontal spread. Albeit affected by the immunoevasive tactics of CMV, mucosal DC remain potent inducers of cellular and humoral immune responses against this virus. Their natural functions could thus be exploited to generate long-lasting protective immunity against CMV by vaccination via the oronasal mucosae. Although related, epithelial Langerhans-type DC and dermal monocyte-derived DC interact with CMV in dramatically different ways. Whereas immature monocyte-derived DC are fully permissive to infection, for instance, immature Langerhans-type DC are completely resistant. Understanding these differences is essential to design innovative vaccines and new antiviral compounds to protect these cells from CMV infection in vivo.

Indexed as

Viral TropismAnimalsCytomegalovirusCytomegalovirus InfectionsDendritic CellsHumansMucous Membrane

Identifiers

PMID24888709
PMCPMC4213286
OpenAlexW1532785077

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.